News
Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with WHO Group 1 PAH FC 3 or 4 at high risk of mortality.
HVEM-BTLA-Fc fusion protein design. (A) Schematic diagram of peptide elements in HVEM-BTLA-Fc fusion protein. (B) The amino acid sequence of HVEM-BTLA-Fc fusion protein. (C) The figure shows the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback